PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Aug-2022 Oligomerix Awarded $3.35M from NIH to Support Clinical Development of Tau-Targeting Alzheimer’s Disease Therapy Businesswire
09-Aug-2022 Protein Expression Global Market Report 2022: Increase in Demand for Biologics to Counter Various Genetic Disorders and Chronic Diseases Propelling Sector - ResearchAndMarkets.com Businesswire
09-Aug-2022 Applied DNA Receives Approximately $3.6 Million in Net Proceeds from Warrant Exercise Businesswire
09-Aug-2022 User / Human Factors Engineering Under IEC 62366-1, -2 Webinar - ResearchAndMarkets.com Businesswire
09-Aug-2022 Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product Businesswire
09-Aug-2022 AdaptHealth Corp. to Host 2022 Capital Markets Day on September 16th Businesswire
09-Aug-2022 CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors Businesswire
09-Aug-2022 Stem Cell Therapy Global Market Report 2022: Rapid Growth in Emerging Markets & An Increase in Investments in Cell and Gene Therapies Driving Growth - ResearchAndMarkets.com Businesswire
09-Aug-2022 6-Hour Virtual Seminar on The Use of Drug Master Files & Quality Agreements: Understanding and Meeting your Regulatory and Processing Responsibilities - ResearchAndMarkets.com Businesswire
09-Aug-2022 Akanda to Supply Cansativa with Premium Indoor Cannabis Flower Grown at its Sintra Facility in Portugal Businesswire
09-Aug-2022 AdaptHealth Reports Second Quarter 2022 Results Businesswire
09-Aug-2022 ADC Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates Businesswire
09-Aug-2022 Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update Businesswire
09-Aug-2022 TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch Businesswire
09-Aug-2022 Global Food Allergen Testing Market 2022-2028: High Growth of Global Food Trade & Stringent Government Regulations Driving Sector - ResearchAndMarkets.com Businesswire
09-Aug-2022 2 Day Virtual Seminar: Risk Management of Raw Materials in a GMP Environment (August 29-30, 2022) - ResearchAndMarkets.com Businesswire
09-Aug-2022 La Comisión Europea aprueba IMBRUVICA® (ibrutinib) en un régimen de combinación de duración fija para pacientes adultos con leucemia linfocítica crónica (LLC) sin tratamiento previo Businesswire
09-Aug-2022 La Commission européenne approuve IMBRUVICA® (ibrutinib) en association à durée fixe pour les patients adultes atteints de leucémie lymphoïde chronique (LLC) précédemment non traitée Businesswire
09-Aug-2022 Europäische Kommission erteilt Zulassung für IMBRUVICA® (ibrutinib) als Kombinationspräparat mit fester Behandlungsdauer für erwachsene Patienten mit zuvor unbehandelter chronischer lymphatischer Leukämie (CLL) Businesswire
09-Aug-2022 Full Day Virtual Seminar on Fundamentals of Pharmacokinetics - ResearchAndMarkets.com Businesswire